LSC Abstract - Glutamatergic signaling through pulmonary vascular NMDA receptors in pulmonary hypertension

Conclusion: Glutamatergic signaling through pulmonary vascular NMDAR occurs in PAH pathophysiology and may represent a new therapeutic target.

Source: European Respiratory Journal - October 30, 2015 Category: Respiratory Medicine Authors: Dumas, S. J., Perros, F., Bru-Mercier, G., Courboulin, A., Ranchoux, B., Rücker-Martin, C., Gouadon, E., Vocelle, M., Raymond, N., Dorfmüller, P., Fadel, E., Humbert, M., Cohen-Kaminsky, S. Tags: 4.3 Pulmonary Circulation and Pulmonary Vascular Disease Source Type: research